Add a listing
    Add a listing

    Rejuvenate Bio

      Gene therapies to extend lifespan of dogs.

    General
    • Founders & Team

      Daniel Oliver, Noah Davidsohn, Jihyun Kim

    • Year Founded

      2017

    • Number of employees

      10

    • Company type

      Private company

    • Funding stage

      Seed

    • Total funding ($M)

      2.2

    • Investors

      Digitalis Ventures, KdT Ventures

    Technical Details
    • Aging Target

      Cell Loss

    • Product modality

      gene therapy

    About

    Rejuvenate Bio is developing a combination of gene therapies to extend lifespan in dogs. Their first program is a therapy for mitral heart valve disease in Cavalier Cocker spaniels.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In